Ensysce Biosciences (ENSC) Financials: Revenue & Earnings

ENSC price $0.45 +0.00 +0.73%

Ticker
ENSC
Price
$0.45
Change
+0.00 +0.73%
Market cap ?
$8.82M
P/E ?
-0.16
Dividend yield ?
0.00%
Beta ?
1.02
Sector
Healthcare
Industry
Biotechnology

Financials

201720182019202020212022202320242025
001763961000000

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose. The company leverages two primary technological frameworks: the Trypsin Activated Abuse Protection (TAAP) platform, which creates opioid prodrugs designed to resist…

Fair value

ENSC fair value $21.89. Price $0.45. Price is 98% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ENSC

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-13—-0.12—1.20M
2026-08-13-0.20-0.201.20M1.20M
2026-05-15-0.52-0.731.00M1.90M
2026-03-30-0.75-1.261.90M502.97K
2025-11-14-1.29-0.85493.10K700.00K
2025-08-13-0.79-1.02—650.00K
2025-05-13-1.39-3.021.31M650.00K
2025-03-19-2.90-2.741.30M245.00K
2024-11-121.05-0.293.41M3.40M
2024-08-14-3.30-0.39200.00K300.00K
2024-05-13-8.25-5.85305.00K400.00K
2024-03-15-16.94-12.89505.00K395.00K
2023-11-09-0.87-15.89420.00K593.33K
2023-08-11-14.69-27.80495.00K760.00K
2023-05-15-31.18-76.15800.00K950.00K
2023-03-30-2.74-0.031.43M1.54M
2022-11-14-9.23-0.03300.00K1.00M
2022-08-11-8.64-7.56200.00K1.00M
2022-05-12-7.20-7.20600.00K1.20M
2022-03-31-16.203.241.00M800.00K
2021-11-15-2,555.74-127.80—1.20M
2021-08-16-215.98-127.80—1.20M
2021-06-08-14.40———
2021-03-153.26———
2020-11-0923.90———
2020-08-07-6.97———
2020-05-07-0.05—862.40K—
2020-03-10-0.11———
2019-11-070.08———
2019-08-070.14———
2019-05-070.13———
2019-03-110.12———
2018-11-070.10———
2018-08-010.07———
2018-05-030.07———
2018-03-09-0.00———
2018-01-09-0.00———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-07GOWER BOB GBuy400.00K$0.49198.00K
2026-08-05Morrison James WilliamOther154.82M——
2026-04-23GOWER BOB GBuy508.61K$0.48246.17K
2026-04-23GOWER BOB GBuy254.31K$0.48123.08K
2023-03-02GOWER BOB GBuy90.29K$0.4944.09K
2023-03-01GOWER BOB GBuy270.00K$0.48128.98K
2023-02-28GOWER BOB GBuy109.30K$0.4953.37K
2022-12-09GOWER BOB GBuy357.14K$1.40500.00K
2022-12-09GOWER BOB GBuy714.29K$1.401.00M
2022-06-23Chang William HBuy15.00K——
2022-06-23Martin Steven RobertBuy15.00K——
2022-06-23Rauch Lee M.Buy15.00K——
2022-06-23GOWER BOB GBuy15.00K$0.426.38K
2022-06-23GOWER BOB GBuy15.00K——
2022-06-23Rosebraugh CurtisBuy20.00K——
2022-06-23Benton AndrewBuy15.00K——
2022-06-23Levin AdamBuy15.00K——
2022-05-25Kirkpatrick LynnBuy200.00K——
2022-05-25Kirkpatrick LynnBuy27.00K$0.5314.22K
2022-04-18Osman NilabSell200.00K$1.07214.00K
2022-02-17Humphrey David CarlBuy80.00K$1.40112.00K
2022-02-17Birkett Kevin GeoffreyBuy50.00K$1.4070.00K
2022-02-17Kirkpatrick LynnBuy200.00K$1.40280.00K
2022-02-08Rauch Lee M.Sell20.00K$1.7034.00K
2022-02-04Benton AndrewBuy20.00K$3.1362.60K
2022-02-04Chang William HBuy20.00K$3.1362.60K
2022-02-04Martin Steven RobertBuy20.00K$3.1362.60K
2022-02-04Levin AdamBuy20.00K$3.1362.60K
2022-02-04Rosebraugh CurtisBuy20.00K$3.1362.60K
2022-02-04GOWER BOB GBuy20.00K$3.1362.60K
2022-02-04Pestano LindaBuy200.00K$2.48496.00K
2022-02-04Humphrey David CarlBuy275.00K$3.13860.75K
2021-10-15Pestano LindaOther0——
2021-06-30Humphrey David CarlBuy50.00K——
2021-06-30Chang William HBuy2.24M——
2021-06-30Chang William HBuy353.45K——
2021-06-30GOWER BOB GBuy7.92M——
2021-06-30GOWER BOB GBuy6.58K$2.5917.06K
2021-06-30Kirkpatrick LynnBuy817.56K$1.681.37M
2021-06-30Kirkpatrick LynnBuy658.50K$2.591.71M
2021-06-30Kirkpatrick LynnBuy460.95K$1.83843.54K
2021-06-30Kirkpatrick LynnBuy284.85K——
2021-06-30Kirkpatrick LynnBuy263.40K$3.19840.25K
2021-06-30Kirkpatrick LynnBuy99.95K$3.21320.84K
2021-06-30Kirkpatrick LynnBuy9.99K$3.2132.08K
2021-06-30Kirkpatrick LynnBuy6.58K$2.5917.06K
2021-06-30Benton AndrewBuy65.85K$3.35220.60K
2021-06-30Martin Steven RobertBuy65.85K$3.35220.60K
2021-06-30Wright Richard ChesterBuy987.75K——
2021-06-30Wright Richard ChesterBuy263.40K——
2021-06-30Wright Richard ChesterBuy65.85K——
2021-06-30Wright Richard ChesterBuy49.98K——
2021-06-30Wright Richard ChesterBuy19.75K——
2021-06-30Schmidt William KBuy69.14K$3.22222.64K
2021-06-30Birkett Kevin GeoffreyBuy329.25K$2.59852.76K
2021-06-30Birkett Kevin GeoffreyBuy19.75K$2.5951.17K
2021-06-30Martin Steven RobertOther0——
2021-06-30Wright Richard ChesterOther0——
2021-06-30Kirkpatrick LynnOther0——
2021-06-30Millard JeffreyOther0——
2021-06-30Birkett Kevin GeoffreyOther0——
2021-06-30Humphrey David CarlOther0——
2021-06-30Rosebraugh CurtisOther0——
2021-06-30GOWER BOB GOther0——
2021-06-30Benton AndrewOther0——
2021-06-30Schmidt William KOther0——
2021-06-30Chang William HOther0——
2021-06-30Levin AdamOther0——
2021-06-30WEIL A LORNEBuy1.00M$11.5011.50M
2021-06-30WEIL A LORNEBuy730.11K$11.508.40M
2021-06-30WEIL A LORNEBuy387.89K$11.504.46M
2021-06-30WEIL A LORNESell250.00K$11.502.88M
2021-06-30Peng GeorgeBuy15.00K$11.50172.50K
2021-06-30Carrera EricBuy30.00K$11.50345.00K
2021-06-30Silvers Daniel B.Buy367.11K$11.504.22M
2021-06-30Silvers Daniel B.Sell250.00K$11.502.88M
2021-06-30Silvers Daniel B.Buy1.64M$11.5018.83M
2020-06-19MORGAN STANLEYSell776.29K$10.448.10M
2020-03-29MORGAN STANLEYOther0——
2020-03-29MORGAN STANLEYOther388.14K——
2018-01-15HG Vora Capital Management, LLCSell375.00K——
2018-01-15WEIL A LORNESell132.16K——
2018-01-15WEIL A LORNESell40.65K——
2018-01-15Peng GeorgeSell13.25K——
2018-01-15Carrera EricSell8.33K——
2018-01-15Silvers Daniel B.Sell171.83K——
2017-12-05Silvers Daniel B.Sell359.87K——
2017-12-05WEIL A LORNESell169.52K——
2017-12-05WEIL A LORNESell187.17K——
2017-12-05HG Vora Capital Management, LLCSell718.75K——
2017-12-05Carrera EricSell1.47K——
2017-12-05Peng GeorgeSell733——
2017-12-01HG Vora Capital Management, LLCBuy1.00M$10.0010.00M
2017-12-01Falcone Marc J.Sell0——
2017-12-01Weinstein David L.Sell0——
2017-12-01Rittvo Steven MSell0——
2017-12-01HG Vora Capital Management, LLCOther0——
2017-12-01Silvers Daniel B.Other0——
2017-12-01Peng GeorgeSell0——
2017-12-01Carrera EricSell0——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Earnings and financials

Ensysce Biosciences, Inc. (ENSC) trades at $0.45, with a market cap of $8.82M and a trailing P/E of -0.16. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
001763961000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Ensysce Biosciences (ENSC) Financials: Revenue & Earnings

ENSC$0.45+0.00 +0.73%

$8.82M

Market Cap

-0.16

P/E

—

Forward P/E

—

Score

Price History